¥19.65
¥0.00 (0.00%)
End-of-day quote: 05/17/2024
SZSE:002007

Hualan Biological Engineering Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Rev. Revenue
¥5.34B ¥4.52B ¥4.44B ¥5.02B ¥3.70B ¥3.22B ¥2.37B ¥1.93B ¥1.47B ¥1.24B ¥1.12B ¥972.46M ¥961.40M ¥1.26B ¥1.22B ¥475.16M ¥351.14M ¥354.99M ¥361.28M
GM % Gross Margin %
67.67% 62.38% 65.33% 72.03% 63.62% 65.03% 61.10% 60.00% 56.21% 60.66% 58.20% 56.44% 67.29% 76.69% 73.70% 60.13% 53.78% 38.68% 33.24%
OM Operating Margin
33.89% 27.08% 35.76% 39.78% 38.97% 37.44% 35.05% 40.28% 39.04% 40.90% 41.28% 30.95% 45.02% 64.44% 63.01% 48.25% 36.74% 26.40% 17.02%
EPS Earnings Per Share
¥0.00 ¥0.69 ¥0.49 ¥0.66 ¥0.81 ¥0.63 ¥0.55 ¥0.42 ¥0.37 ¥0.28 ¥0.25 ¥0.23 ¥0.14 ¥0.20 ¥0.33 ¥0.33 ¥0.10 ¥0.06 ¥0.05 ¥0.03
Div. Dividends
¥0.30 ¥0.30 ¥0.20 ¥0.30 ¥0.31 ¥0.21 ¥0.15 ¥0.21 ¥0.13 ¥0.19 ¥0.13 ¥0.03 ¥0.04 ¥0.00 ¥0.06 ¥0.00 ¥0.00 ¥0.00 ¥0.00
PR % Payout Ratio %
43.48% 61.22% 30.30% 37.04% 49.21% 38.18% 35.71% 56.76% 46.43% 76.00% 56.52% 21.43% 20.00% 0 18.18% 0 0 0 0
Sha. Shares
1828.78m 1824.37m 1824.37m 1824.37m 1823.98m 1813.67m 1813.67m 1813.67m 1813.67m 1813.67m 1812.45m 1797.76m 1797.76m 1797.76m 1797.76m 1797.76m 1733.86m 1733.86m 1733.86m
OCF Operating Cash Flow
¥1.35B ¥957.31M ¥1.43B ¥1.33B ¥1.36B ¥1.29B ¥177.42M ¥329.94M ¥548.62M ¥497.15M ¥510.70M ¥494.69M ¥335.93M ¥609.53M ¥607.73M ¥161.18M ¥179.02M ¥131.43M ¥98.24M
FCF Free Cash Flow
¥1.81B ¥613.69M ¥622.06M ¥703.96M ¥1.09B ¥1.11B ¥76.09M ¥109.58M ¥319.39M ¥358.93M ¥261.80M ¥347.54M ¥192.80M ¥459.88M ¥448.24M ¥34.36M ¥-34.90M ¥-70.54M ¥39.65M
FCFS Free Cash Flow Per Share
¥0.32 ¥0.31 ¥0.34 ¥0.39 ¥0.60 ¥0.61 ¥0.04 ¥0.06 ¥0.18 ¥0.20 ¥0.15 ¥0.19 ¥0.11 ¥0.26 ¥0.25 ¥0.02 ¥-0.02 ¥-0.04 ¥0.02